O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.47%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$6.34B
AUM Growth
+$6.34B
(-0.66%)
Cap. Flow
-$66.5M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
40.11%
Holding
139
New
17
Increased
27
Reduced
20
Closed
14
Top Buys
| 1 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$182M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$104M |
| 3 |
uniQure
QURE
|
$70.2M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$67.5M |
| 5 |
Natera
NTRA
|
$59.2M |
Top Sells
| 1 |
CMTA
Clementia Pharmaceuticals Inc.
CMTA
|
$272M |
| 2 |
Guardant Health
GH
|
$118M |
| 3 |
Viatris
VTRS
|
$66.4M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$64M |
| 5 |
Humana
HUM
|
$55.9M |
Sector Composition
| 1 | Healthcare | 97.38% |
| 2 | Financials | 1.24% |
